Novotech, the leading Asia Pacific-centered biotech CRO announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group. CBR was founded in 2002 as a consultancy company focused on assisting biotechnology and pharma companies navigate FDA requirements from early-stage development through to approval. CBR adds a group of experts […]

The post Novotech Acquires US-based Drug Development Consulting Firm, CBR International first appeared on World Pharma Today.